TIBAY AT LIWANAG NG BUKAS (The Strength and Light of Tomorrow): The Launch That Made Doctors Feel the Science

In 2024 and 2025, BBX Collab collaborated with Corbridge Group Philippines to launch two diabetes medications—Vildaxil and Catania—through immersive and experimental launch programs that redefined how healthcare brands communicate with medical professionals.



Instead of relying on conventional lectures and clinical decks, BBX Collab’s team of Creative Scientists created two fully staged, original musical productions: Tibay ng Bukas (Strength of Tomorrow) and its sequel Liwanag ng Bukas (Light of Tomorrow). Each production was designed to shed a light on how diabetes affects not just patients but health care professionals as well, making those same doctors not only understand the science, but feel the stakes of diabetes care.



Both launches fused three traditionally separate experiences into one seamless journey:

(1) musical storytelling centered on Filipino patients and caregivers,

(2) an expert-led scientific discussion, and

(3) a theatrical product unveiling positioned as a turning point in the narrative.



Tibay ng Bukas utilized the Filipino tradition of harana—serenading the medical community into a shared commitment to fight diabetes through strength, or tibay. Its structure moved from the problem, to solution, to collective pledge.



In 2025, BBX Collab grew the story by creating a sequel: Liwanag ng Bukas, introducing new characters, challenges, and a new partner product: Catania. The sequel deepened immersion through on-ground experience design and digital gamification while still keeping the same emotional-to-scientific arc.



The result: hundreds of healthcare professionals from across hundreds of hospitals and medical institutions across Luzon, Visayas, and Mindanao were reached through one unique launch experience.



Together, these launches proved that healthcare advertising can be revolutionized: not by making medicine louder, but by making it human, unforgettable, and belief-building.